Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M786Revenue (TTM) $M6.0Net Margin (%)-893.6Altman Z-Score1.8
Enterprise Value $M661EPS (TTM) $-0.4Operating Margin %-894.2Piotroski F-Score4
P/E(ttm)--Beneish M-Score1.6Pre-tax Margin (%)-893.6Higher ROA y-yY
Price/Book10.110-y EBITDA Growth Rate %-9.6Quick Ratio8.1Cash flow > EarningsY
Price/Sales1305-y EBITDA Growth Rate %-1.4Current Ratio8.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-37.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-55.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M132ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZIOPJoel Greenblatt 2016-03-31 Reduce$4.89 - $9.59
($6.81)
$ 5.96-12%Reduce -12.49%96,406
ZIOPJoel Greenblatt 2015-12-31 Buy 0.01%$8.07 - $14.57
($11.04)
$ 5.96-46%New holding110,163
ZIOPJoel Greenblatt 2015-06-30 Sold Out -0.01%$8.81 - $12.5
($10.36)
$ 5.96-42%Sold Out0
ZIOPJoel Greenblatt 2015-03-31 Buy 0.01%$4.96 - $14
($9.88)
$ 5.96-40%New holding109,080
ZIOPFirst Eagle Investment 2013-06-30 Sold Out -0.0012%$1.52 - $2.62
($1.86)
$ 5.96220%Sold Out0
ZIOPFirst Eagle Investment 2013-03-31 Buy $1.72 - $5.71
($4.42)
$ 5.9635%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZIOP is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BELBEL CAESAR JCOO, CLO, and Secretary 2015-11-19Sell153,333$12.84-53.58view
LEBEL FRANCOISExecutive Vice President R&D 2015-06-09Sell50,000$10.12-41.11view
BRENNAN MURRAYDirector 2015-06-04Sell40,000$9.7-38.56view
Lafond Kevin GVice Pres., Treasurer, & CAO 2015-06-03Sell57,500$9.65-38.24view
KIRK RANDAL JDirector, 10% Owner 2015-02-09Buy1,440,000$8.75-31.89view
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.570.29view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.214.62view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.9919.44view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.9221.14view
Fowler WycheDirector 2011-08-10Buy5,000$5.1914.84view

Quarterly/Annual Reports about ZIOP:

News about ZIOP:

Articles On GuruFocus.com
Intrexon Corp is expanding his business Jun 25 2015 
Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 
Bass’ New Buy – ZIOPHARM Oncology Inc. May 16 2013 
The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 

More From Other Websites
ZIOPHARM ONCOLOGY INC Files SEC form 8-K/A, Amendments to Articles of Inc. or Bylaws; Change in... Jul 01 2016
ETF’s with exposure to ZIOPHARM Oncology, Inc. : June 30, 2016 Jun 30 2016
Ziopharm Co-Dependency Spirals Down in Amended Intrexon Deal Jun 30 2016
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered... Jun 30 2016
Intrexon and ZIOPHARM Amend Exclusive Channel Collaborations to Improve Alignment as Programs... Jun 30 2016
8:03 am ZIOPHARM and Intrexon (XON) amend their Exclusive Channel... Jun 30 2016
Intrexon and ZIOPHARM Amend Exclusive Channel Collaborations to Improve Alignment as Programs... Jun 30 2016
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jun 27 2016
ZIOPHARM Completes Enrollment in Second Patient Cohort and Initiates Enrollment in Third Cohort in... Jun 27 2016
ZIOPHARM Completes Enrollment in Second Patient Cohort and Initiates Enrollment in Third Cohort in... Jun 27 2016
Research Report Initiated on Select Biotechnology Equities Jun 24 2016
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 15 2016
ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jun 09 2016
ETF’s with exposure to ZIOPHARM Oncology, Inc. : June 6, 2016 Jun 06 2016
Biotech Stocks: Are They Back? Jun 02 2016
Coverage initiated on ZIOPHARM by Raymond James Jun 02 2016
ZIOPHARM to Present at the Jefferies 2016 Healthcare Conference Jun 02 2016
ZIOPHARM to Present at the Jefferies 2016 Healthcare Conference Jun 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)